Home › Upcoming votes › Autonomix Medical, Inc.
This meeting took place on October 29, 2026. Official results not yet filed. Companies report them on Form 8-K, usually within four business days of the meeting; they will appear here once they have been read.
The deadline as the proxy statement states it: “Voting over the Internet: If you are a stockholder of record, you may use the Internet to transmit your vote up until 10:59 PM, Central Time, October 28, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Autonomix Medical, Inc.’s proxy statement, with the board’s recommendation on each item. The company has filed 1 set of additional materials since; they can add to or change what is below, so check them before relying on it.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | ELECTION OF DIRECTORS Director election |
Board | For | 5 nominees; support 93% to 97% |
| 2 | TO RATIFY THE APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Auditor |
Board | For | 97% support |
| 3 | TO GRANT BOARD OF DIRECTORS AUTHORITY TO EFFECT A REVERSE STOCK SPLIT OF THE OUTSTANDING SHARES OF THE COMPANY'S COMMON STOCK | Board | For | — |
| 4 | TO APPROVE AN AMENDMENT TO THE AUTONOMIX MEDICAL, INC. 2023 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE THEREUNDER | Board | For | — |
From Autonomix Medical, Inc.’s Form 8-K, filed November 3, 2025, for the meeting held October 30, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Walter V. Klemp | 97% | Elected |
| Elect Director: Lori Bisson | 96% | Elected |
| Elect Director: Jonathan P. Foster | 97% | Elected |
| Elect Director: David Robins | 93% | Elected |
| Elect Director: Christopher Capelli | 94% | Elected |
| 2. To ratify the appointment of Forvis Mazars, LLP as the Company's independent registered public accounting firm for the year ending March | 97% | — |
| 3. To approve an amendment to the Company's amended and restated certificate of incorporation to grant our Board of Directors authority to a | 84% | — |
| 4. To approve the amended and restated 2023 Equity Incentive Plan | 90% | — |
| 5. To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of more than 20% of the Company's issued and outstan | 94% | — |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.